Merck & Co., Inc. (MRK)
NYSE: MRK · IEX Real-Time Price · USD
126.94
+1.16 (0.92%)
At close: Apr 22, 2024, 4:00 PM
127.40
+0.46 (0.36%)
Pre-market: Apr 23, 2024, 8:27 AM EDT
Merck & Co. Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Merck & Co. stock have an average target of 131.08, with a low estimate of 104 and a high estimate of 148. The average target predicts an increase of 3.26% from the current stock price of 126.94.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Merck & Co. stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 8 | 8 | 7 | 8 | 6 | 4 |
Buy | 8 | 8 | 9 | 6 | 5 | 5 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
Total | 19 | 19 | 19 | 17 | 15 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $135 | Buy | Reiterates | $135 | +6.35% | Apr 18, 2024 |
Berenberg | Berenberg | Strong Buy Maintains $140 → $143 | Strong Buy | Maintains | $140 → $143 | +12.65% | Apr 8, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $135 | Buy | Reiterates | $135 | +6.35% | Apr 5, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $135 | Buy | Reiterates | $135 | +6.35% | Apr 1, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $139 → $142 | Strong Buy | Reiterates | $139 → $142 | +11.86% | Mar 28, 2024 |
Financial Forecast
Revenue This Year
64.47B
from 60.12B
Increased by 7.24%
Revenue Next Year
68.63B
from 64.47B
Increased by 6.45%
EPS This Year
8.66
from 0.14
Increased by 6,086.38%
EPS Next Year
9.87
from 8.66
Increased by 14.00%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 68.2B | 73.9B | 80.1B | 80.7B | 84.9B |
Avg | 64.5B | 68.6B | 72.5B | 73.4B | 75.4B |
Low | 61.5B | 64.8B | 67.0B | 65.6B | 67.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 13.5% | 14.6% | 16.7% | 11.3% | 15.7% |
Avg | 7.2% | 6.5% | 5.7% | 1.2% | 2.7% |
Low | 2.3% | 0.4% | -2.3% | -9.6% | -7.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.36 | 11.03 | 12.26 | 12.83 | 14.39 |
Avg | 8.66 | 9.87 | 10.88 | 11.15 | 11.67 |
Low | 8.27 | 8.94 | 9.37 | 9.16 | 9.56 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 6,582.5% | 27.3% | 24.2% | 17.9% | 29.0% |
Avg | 6,086.4% | 14.0% | 10.2% | 2.4% | 4.7% |
Low | 5,808.0% | 3.2% | -5.1% | -15.8% | -14.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.